HUE055411T2 - Engineered ligase variants - Google Patents
Engineered ligase variantsInfo
- Publication number
- HUE055411T2 HUE055411T2 HUE18798770A HUE18798770A HUE055411T2 HU E055411 T2 HUE055411 T2 HU E055411T2 HU E18798770 A HUE18798770 A HU E18798770A HU E18798770 A HUE18798770 A HU E18798770A HU E055411 T2 HUE055411 T2 HU E055411T2
- Authority
- HU
- Hungary
- Prior art keywords
- engineered ligase
- ligase variants
- variants
- engineered
- ligase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y605/00—Ligases forming phosphoric ester bonds (6.5)
- C12Y605/01—Ligases forming phosphoric ester bonds (6.5) forming phosphoric ester bonds (6.5.1)
- C12Y605/01001—DNA ligase (ATP) (6.5.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2521/00—Reaction characterised by the enzymatic activity
- C12Q2521/50—Other enzymatic activities
- C12Q2521/501—Ligase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
- C12Q2525/10—Modifications characterised by
- C12Q2525/191—Modifications characterised by incorporating an adaptor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
- C12Q2535/122—Massive parallel sequencing
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762503075P | 2017-05-08 | 2017-05-08 | |
US201762540734P | 2017-08-03 | 2017-08-03 | |
US201762587030P | 2017-11-16 | 2017-11-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
HUE055411T2 true HUE055411T2 (en) | 2021-11-29 |
Family
ID=64014642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HUE18798770A HUE055411T2 (en) | 2017-05-08 | 2018-05-07 | Engineered ligase variants |
Country Status (15)
Country | Link |
---|---|
US (1) | US20180320162A1 (en) |
EP (2) | EP3635101B1 (en) |
JP (2) | JP7401902B2 (en) |
KR (1) | KR20200003903A (en) |
CN (1) | CN110914415B (en) |
AU (1) | AU2018266606B2 (en) |
BR (1) | BR112019023337A2 (en) |
CA (1) | CA3062550A1 (en) |
DK (1) | DK3635101T3 (en) |
ES (1) | ES2887078T3 (en) |
HU (1) | HUE055411T2 (en) |
MX (1) | MX2019013289A (en) |
PL (1) | PL3635101T3 (en) |
SG (1) | SG11201909957TA (en) |
WO (1) | WO2018208665A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10837009B1 (en) | 2017-12-22 | 2020-11-17 | New England Biolabs, Inc. | DNA ligase variants |
EP3906318A1 (en) | 2019-01-06 | 2021-11-10 | 10X Genomics, Inc. | Methods and systems for enrichment of barcodes |
CN113811619A (en) | 2019-03-27 | 2021-12-17 | 10X基因组学有限公司 | Systems and methods for processing RNA from cells |
CN113774032B (en) * | 2021-11-12 | 2022-03-01 | 翌圣生物科技(上海)股份有限公司 | Recombinant T4 ligase mutant, coding DNA and NGS library construction method |
US11685913B1 (en) * | 2022-02-18 | 2023-06-27 | Abclonal Science, Inc. | T4 DNA ligase variants with increased resistance to salt |
US11788082B2 (en) * | 2022-02-22 | 2023-10-17 | Abclonal Science, Inc. | T4 DNA ligase variants with increased thermostability |
US20230295707A1 (en) * | 2022-03-21 | 2023-09-21 | Abclonal Science, Inc. | T4 DNA Ligase Variants with Increased Ligation Efficiency |
WO2024123733A1 (en) * | 2022-12-05 | 2024-06-13 | Twist Bioscience Corporation | Enzymes for library preparation |
CN115896047B (en) * | 2022-12-12 | 2023-06-16 | 南京诺唯赞生物科技股份有限公司 | Recombinant T4DNA ligase mutant, fusion protein and application thereof |
WO2024138664A1 (en) * | 2022-12-30 | 2024-07-04 | 深圳华大生命科学研究院 | Nucleic acid ligase and use thereof |
CN118291587A (en) * | 2023-01-03 | 2024-07-05 | 南京诺唯赞生物科技股份有限公司 | Composition and application thereof in nucleic acid purification |
US20240309353A1 (en) * | 2023-01-23 | 2024-09-19 | Codexis, Inc. | Engineered dna ligase variants |
CN117946985B (en) * | 2024-03-27 | 2024-05-28 | 翌圣生物科技(上海)股份有限公司 | Mutant T4 DNA ligase, kit and application thereof in library construction |
Family Cites Families (69)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6309883B1 (en) | 1994-02-17 | 2001-10-30 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US6395547B1 (en) | 1994-02-17 | 2002-05-28 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US20060257890A1 (en) | 1996-05-20 | 2006-11-16 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US5928905A (en) | 1995-04-18 | 1999-07-27 | Glaxo Group Limited | End-complementary polymerase reaction |
US5834252A (en) | 1995-04-18 | 1998-11-10 | Glaxo Group Limited | End-complementary polymerase reaction |
US6406855B1 (en) | 1994-02-17 | 2002-06-18 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
US6995017B1 (en) | 1994-02-17 | 2006-02-07 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US6165793A (en) | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
CN1192108C (en) | 1994-06-03 | 2005-03-09 | 诺沃奇梅兹生物技术有限公司 | Purified myceliophthora laccase and nucleic acid encoding same |
ATE294871T1 (en) | 1994-06-30 | 2005-05-15 | Novozymes Biotech Inc | NON-TOXIC, NON-TOXIGEN, NON-PATHOGENIC FUSARIUM EXPRESSION SYSTEM AND PROMOTORS AND TERMINATORS FOR USE THEREIN |
FI104465B (en) | 1995-06-14 | 2000-02-15 | Valio Oy | Protein hydrolyzates for the treatment and prevention of allergies and their preparation and use |
US6096548A (en) | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
US6506602B1 (en) | 1996-03-25 | 2003-01-14 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
AU6029998A (en) | 1997-01-17 | 1998-08-07 | Regents Of The University Of Minnesota | Dna molecules and protein displaying improved triazine compound degrading ability |
DK1717322T3 (en) | 1997-01-17 | 2012-10-22 | Codexis Mayflower Holdings Llc | Development of whole cells and organisms by recursive sequence recombination |
US7148054B2 (en) | 1997-01-17 | 2006-12-12 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
US6326204B1 (en) | 1997-01-17 | 2001-12-04 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
EP1036198B1 (en) | 1997-12-08 | 2012-09-26 | California Institute Of Technology | Method for creating polynucleotide and polypeptide sequences |
IL138800A0 (en) | 1998-04-02 | 2001-10-31 | Tellus Genetic Resources Inc | A method of identifying a plant with a lesion in a gene sequence |
BR9910174A (en) | 1998-05-01 | 2001-03-06 | Maxygen Inc | Process for obtaining an optimized recombinant gene for pest resistance, library, and process for obtaining an organism that is pathogenic to a vegetable pest |
EP1090024A2 (en) | 1998-06-17 | 2001-04-11 | Maxygen, Inc. | Method for producing polynucleotides with desired properties |
US6365408B1 (en) | 1998-06-19 | 2002-04-02 | Maxygen, Inc. | Methods of evolving a polynucleotides by mutagenesis and recombination |
AU5347999A (en) | 1998-08-12 | 2000-03-06 | Maxygen, Inc. | Dna shuffling of monooxygenase genes for production of industrial chemicals |
JP2002526107A (en) | 1998-10-07 | 2002-08-20 | マキシジェン, インコーポレイテッド | DNA shuffling to generate nucleic acids for mycotoxin detoxification |
EP1129184A1 (en) | 1998-11-10 | 2001-09-05 | Maxygen, Inc. | Modified adp-glucose pyrophosphorylase for improvement and optimation of plant phenotypes |
JP4221100B2 (en) | 1999-01-13 | 2009-02-12 | エルピーダメモリ株式会社 | Semiconductor device |
US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US6917882B2 (en) | 1999-01-19 | 2005-07-12 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
US6436675B1 (en) | 1999-09-28 | 2002-08-20 | Maxygen, Inc. | Use of codon-varied oligonucleotide synthesis for synthetic shuffling |
US6368861B1 (en) | 1999-01-19 | 2002-04-09 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US7702464B1 (en) | 2001-08-21 | 2010-04-20 | Maxygen, Inc. | Method and apparatus for codon determining |
AU3210100A (en) | 1999-01-19 | 2000-08-01 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
US20070065838A1 (en) | 1999-01-19 | 2007-03-22 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
US8457903B1 (en) | 1999-01-19 | 2013-06-04 | Codexis Mayflower Holdings, Llc | Method and/or apparatus for determining codons |
US6961664B2 (en) | 1999-01-19 | 2005-11-01 | Maxygen | Methods of populating data structures for use in evolutionary simulations |
US7873477B1 (en) | 2001-08-21 | 2011-01-18 | Codexis Mayflower Holdings, Llc | Method and system using systematically varied data libraries |
US7024312B1 (en) | 1999-01-19 | 2006-04-04 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
IL144657A0 (en) | 1999-02-11 | 2002-06-30 | Maxygen Inc | High throughput mass spectrometry |
CA2364997A1 (en) | 1999-03-05 | 2000-09-08 | Maxygen, Inc. | Encryption of traits using split gene sequences |
US6703240B1 (en) | 1999-04-13 | 2004-03-09 | Maxygar, Inc. | Modified starch metabolism enzymes and encoding genes for improvement and optimization of plant phenotypes |
US7430477B2 (en) | 1999-10-12 | 2008-09-30 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
US6519065B1 (en) | 1999-11-05 | 2003-02-11 | Jds Fitel Inc. | Chromatic dispersion compensation device |
US6686515B1 (en) | 1999-11-23 | 2004-02-03 | Maxygen, Inc. | Homologous recombination in plants |
SG121902A1 (en) | 2000-01-11 | 2006-05-26 | Maxygen Inc | Integrated systems for diversity generation and screening |
WO2001075767A2 (en) | 2000-03-30 | 2001-10-11 | Maxygen, Inc. | In silico cross-over site selection |
JP2004508011A (en) | 2000-04-03 | 2004-03-18 | マキシジェン, インコーポレイテッド | Subtilisin mutant |
DK2278509T3 (en) | 2002-03-01 | 2014-12-15 | Codexis Mayflower Holdings Llc | Methods, systems and software for identification of functional biomolecules |
US7747391B2 (en) | 2002-03-01 | 2010-06-29 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
US20050084907A1 (en) | 2002-03-01 | 2005-04-21 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
US7620500B2 (en) | 2002-03-09 | 2009-11-17 | Maxygen, Inc. | Optimization of crossover points for directed evolution |
US7629157B2 (en) | 2003-08-11 | 2009-12-08 | Codexis, Inc. | Ketoreductase polypeptides and related polynucleotides |
DK2250595T3 (en) | 2008-02-12 | 2017-09-04 | Codexis Inc | PROCEDURE FOR SELECTING AN OPTIMIZED VARIETY OF VARIETIES |
US8768871B2 (en) | 2008-02-12 | 2014-07-01 | Codexis, Inc. | Method of generating an optimized, diverse population of variants |
US8383346B2 (en) | 2008-06-13 | 2013-02-26 | Codexis, Inc. | Combined automated parallel synthesis of polynucleotide variants |
US20090312196A1 (en) | 2008-06-13 | 2009-12-17 | Codexis, Inc. | Method of synthesizing polynucleotide variants |
WO2009152336A1 (en) | 2008-06-13 | 2009-12-17 | Codexis, Inc. | Method of synthesizing polynucleotide variants |
AU2010296086A1 (en) * | 2009-09-16 | 2012-05-10 | Massey University | Fusion polypeptides and uses thereof |
EP2705157B1 (en) | 2011-05-06 | 2017-02-01 | New England Biolabs, Inc. | Ligation enhancement |
HUE042817T2 (en) | 2011-06-28 | 2019-07-29 | Codexis Inc | Protein variant generation by region shuffling |
US20150010525A1 (en) * | 2012-01-23 | 2015-01-08 | The Regents Of The University Of California | Catalytic Tagging System to Study Macro-Molecular Interactions Using Engineered Ubiquitin Ligase and Ubiquitin-Like Proteins to Facilitate Substrate Identification |
US20150133698A1 (en) | 2012-04-20 | 2015-05-14 | Codexis, Inc. | Production of fatty alcohols from engineered microorganisms |
WO2014145269A1 (en) | 2013-03-15 | 2014-09-18 | Theranos, Inc. | Thermostable blunt-end ligase and methods of use |
KR102342205B1 (en) | 2013-09-27 | 2021-12-21 | 코덱시스, 인코포레이티드 | Automated screening of enzyme variants |
GB201612011D0 (en) * | 2016-07-11 | 2016-08-24 | Glaxosmithkline Ip Dev Ltd | Novel processes for the production of oligonucleotides |
US10837009B1 (en) * | 2017-12-22 | 2020-11-17 | New England Biolabs, Inc. | DNA ligase variants |
-
2018
- 2018-05-07 CA CA3062550A patent/CA3062550A1/en active Pending
- 2018-05-07 SG SG11201909957T patent/SG11201909957TA/en unknown
- 2018-05-07 ES ES18798770T patent/ES2887078T3/en active Active
- 2018-05-07 US US15/972,919 patent/US20180320162A1/en active Pending
- 2018-05-07 EP EP18798770.6A patent/EP3635101B1/en active Active
- 2018-05-07 PL PL18798770T patent/PL3635101T3/en unknown
- 2018-05-07 BR BR112019023337-7A patent/BR112019023337A2/en unknown
- 2018-05-07 WO PCT/US2018/031376 patent/WO2018208665A1/en unknown
- 2018-05-07 EP EP21191485.8A patent/EP3957723A3/en active Pending
- 2018-05-07 AU AU2018266606A patent/AU2018266606B2/en active Active
- 2018-05-07 CN CN201880046316.0A patent/CN110914415B/en active Active
- 2018-05-07 JP JP2019561258A patent/JP7401902B2/en active Active
- 2018-05-07 KR KR1020197036043A patent/KR20200003903A/en not_active Application Discontinuation
- 2018-05-07 MX MX2019013289A patent/MX2019013289A/en unknown
- 2018-05-07 HU HUE18798770A patent/HUE055411T2/en unknown
- 2018-05-07 DK DK18798770.6T patent/DK3635101T3/en active
-
2023
- 2023-09-19 JP JP2023150987A patent/JP2023166579A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3635101B1 (en) | 2021-08-18 |
WO2018208665A1 (en) | 2018-11-15 |
EP3635101A4 (en) | 2020-09-30 |
EP3957723A3 (en) | 2022-04-20 |
KR20200003903A (en) | 2020-01-10 |
EP3635101A1 (en) | 2020-04-15 |
JP2023166579A (en) | 2023-11-21 |
CN110914415B (en) | 2024-09-17 |
JP7401902B2 (en) | 2023-12-20 |
US20180320162A1 (en) | 2018-11-08 |
SG11201909957TA (en) | 2019-11-28 |
DK3635101T3 (en) | 2021-09-20 |
BR112019023337A2 (en) | 2020-06-16 |
AU2018266606B2 (en) | 2024-09-05 |
CN110914415A (en) | 2020-03-24 |
MX2019013289A (en) | 2020-01-15 |
PL3635101T3 (en) | 2021-12-13 |
ES2887078T3 (en) | 2021-12-21 |
CA3062550A1 (en) | 2018-11-15 |
JP2020518278A (en) | 2020-06-25 |
EP3957723A2 (en) | 2022-02-23 |
AU2018266606A1 (en) | 2019-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL3635101T3 (en) | Engineered ligase variants | |
HK1257480A1 (en) | Engineered virus | |
HK1257676A1 (en) | Engineered crispr-cas9 nucleases | |
GB201809886D0 (en) | No title | |
IL251822A0 (en) | Interferon alpha2b variants | |
GB201801962D0 (en) | No title | |
GB201904929D0 (en) | No title | |
GB201717717D0 (en) | No title | |
GB201714803D0 (en) | No Title | |
GB201819470D0 (en) | No title | |
ZA202001147B (en) | Construction component | |
HRP20190089T1 (en) | Vortioxetine pyroglutamate | |
GB201802230D0 (en) | No title | |
GB201805111D0 (en) | No title | |
HK1251001A1 (en) | Il-37 variants | |
GB201721012D0 (en) | No title | |
GB201903157D0 (en) | No title | |
GB201810211D0 (en) | Foregin title | |
GB201720631D0 (en) | No title | |
GB201705572D0 (en) | No title | |
GB201721710D0 (en) | No title | |
GB201818557D0 (en) | No title | |
GB201720509D0 (en) | No title | |
GB201811831D0 (en) | No title | |
GB201817796D0 (en) | No title |